Nishino Ichizo
Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8502, Japan.
Curr Neurol Neurosci Rep. 2003 Jan;3(1):64-9. doi: 10.1007/s11910-003-0040-y.
Hereditary myopathies characterized by the development of autophagic vacuoles can be categorized into three groups: rimmed vacuolar myopathies, acid maltase deficiency (glycogen storage disease type II), and myopathies characterized by the autophagic vacuoles with unique vacuolar membranes. Rimmed vacuolar myopathies are most likely secondary lysosomal myopathies because all of the identified causative genes encode extralysosomal proteins. Deficiency of acid maltase, a lysosomal enzyme, has been well characterized clinically, pathologically, biochemically, and genetically, and may become treatable in the near future. The diseases in the last category are relatively rare, but appear to be genetically heterogeneous and the list of these diseases is expanding. Danon disease, the best-characterized disorder in this group, is caused by primary deficiency of a lysosomal membrane protein, LAMP-2. Therefore, diseases in this category are expected to be primary lysosomal disease.
镶边空泡性肌病、酸性麦芽糖酶缺乏症(糖原贮积病II型)以及以具有独特空泡膜的自噬泡为特征的肌病。镶边空泡性肌病很可能是继发性溶酶体肌病,因为所有已确定的致病基因都编码溶酶体外蛋白。酸性麦芽糖酶作为一种溶酶体酶,其缺乏在临床、病理、生化和遗传学方面都有充分的特征描述,并且在不久的将来可能会成为可治疗的疾病。最后一类疾病相对罕见,但似乎具有遗传异质性,且这类疾病的种类正在增加。丹农病是该组中特征最明确的疾病,由溶酶体膜蛋白LAMP - 2原发性缺乏引起。因此,这类疾病预计为原发性溶酶体疾病。